DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Lovenox (Enoxaparin Sodium) - Current Clinical Trials

 
 



Lovenox Related Clinical Trials

Efficacy and Safety of the LovenoxTM (Enoxaparin) Versus HeparinTM Gynecologic Oncology Patients [Recruiting]

Safety Evaluation of Use Sodic Enoxaparin [Completed]

Prophylactic Use of Sodium Enoxaparin for Venous Thromboembolism in High-Risk Abdominal Surgery [Not yet recruiting]

Comparison of Anti-Xa Activity of ENOXA � Versus LOVENOX � in Acute Coronary Syndrome [Recruiting]

Prevention of Maternal and Perinatal Complications by Enoxaparin in Women With Previous Severe Preeclampsia [Recruiting]

Enoxaparin Thromboprophylaxis in Cancer Patients With Elevated Tissue Factor Bearing Microparticles [Recruiting]

A Pilot Study Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients [Recruiting]

Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome [Recruiting]

Once Daily Enoxaparin for Outpatient Treatment of Acute DVT and/or Pulmonary Embolism [Active, not recruiting]

Taxotere-Enoxaparin-(ENOXA)-Study [Recruiting]

Echo-Doppler Assessment of the Occurrence of Asymptomatic DVT in Orthopedic Replacement Surgery Under Enoxaparin [Recruiting]

Enoxaparin in Children With Asymptomatic Venous Thrombosis After Pediatric Cardiac Surgery [Recruiting]

Patients With High-risk Acute Coronary Syndrome Without ST-segment Elevation [Recruiting]

Adjusted Value of Thromboprophylaxis in Hospitalized Obese Patients: A Comparative Study of Two Regimens of Enoxaparin [Not yet recruiting]

Comparison of Subcutaneous Heparin and Enoxaparin for Deep Venous Thrombosis (DVT) Prophylaxis in Surgical Intensive Care Patients [Recruiting]

Enoxaparin Versus Aspirin in Patients With Cancer and Stroke [Recruiting]

Comparison of Arixtra vs. Lovenox to Prevent Blood Clots in Medically Ill Patients [Recruiting]

Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI) [Recruiting]

STEMI Treated With Primary Angioplasty and Intravenous Lovenox or Unfractionated Heparin (UFH) [Recruiting]

Study to Evaluate Weight-Based Enoxaparin Dosing in Obese Medical Patients at Risk for DVT [Completed]

Venous Thromboembolic Prophylaxis After Major Trauma: A Trial of Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin [Recruiting]

LV Thrombus Pilot Study for Comparing Enoxaparin Vs. Warfarin [Completed]

Comparison of 2 Low Molecular Heparin as a Thromboprophylaxis Postpartum [Recruiting]

A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer [Recruiting]

The Effect of Vasopressors on the Anti Xa Response to Enoxaparin in Critically Ill Patients [Recruiting]

The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With Enoxaparin [Recruiting]

Enoxaparin Low Molecular Weight Heparin (LMWH) in Advanced Non Small Cell Lung Cancer: Effect on Survival and Symptom Control in Patients Undergoing First Line Chemotherapy (SYRINGES) [Recruiting]

The Effect of Enoxaparin Sodium on the Incidence of Deep Vein Thrombosis Following Electrophysiology Studies and Radiofrequency Ablation. [Recruiting]

Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver Toxicity [Recruiting]

Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology [Recruiting]

The STREAM Percutaneous Coronary Intervention Anticoagulant Sub-study [Recruiting]

Chemotherapy With or Without Enoxaparin in Pancreatic Cancer [Recruiting]

Enoxaparin and/or Minocycline in Acute Stroke [Not yet recruiting]

Prevention of Unexplained Recurrent Abortion by Enoxaparine [Recruiting]

Clot Dissolving Treatment for Blood Clots in the Lungs [Recruiting]

Enoxaparin as Treatment for Vulvodynia [Recruiting]

New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip or Knee Replacement Surgery [Completed]

Enoxaparin in Acute Venous Thromboembolic Disease [Active, not recruiting]

Prophylactic Enoxaparin Dosing for Prevention of Venous Thromboembolism in Pregnancy - a Prospective Randomized Trial [Recruiting]

Study to Evaluate the Mortality Reduction of Enoxaparin in Hospitalized Acutely Ill Medical Receiving Enoxaparin [Recruiting]

Adaptation Dose of Enoxaparin in Moderate Renal Failure Patients With Acute Coronary Syndrome. [Not yet recruiting]

Enoxaparin Versus Unfractionated Heparin in PCI [Completed]

Study of Apixaban for the Prevention of Thrombosis-Related Events Following Knee Replacement Surgery [Active, not recruiting]

Japanese Safety and Efficacy Study of Enoxaparin in Patients With Hip Fracture Surgery [Completed]

Ischemia Driven Enoxaparin Therapy in ACS Presenting as Low Risk (IDEAL) [Recruiting]

Anticoagulation Post Laparoscopic Splenectomy [Recruiting]

Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II) [Completed]

Docetaxel and Liposomal Doxorubicin Chemotherapy With Enoxaparin in Patients With Advanced Pancreatic Cancer [Recruiting]

Identification and Treatment of Clinically Silent Catheter-Related Deep Vein Thrombosis in Children With Cancer [Recruiting]

PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin) [Completed]

Adjuvant Treatment of Pulmonary Embolism With Drotrecogin Alfa (Activated): Phase II Exploratory Study [Completed]

Study of an Investigational Drug for the Prevention of Thrombosis-Related Events Following Knee Replacement Surgery [Recruiting]

HENOX: Enoxaparine in Hemodialysis [Completed]

Total Hip Replacement Study With XRP4563 (Enoxaparin Sodium) [Completed]

Once Weekly Subcutaneous Ports for the Administration of Enoxaparin [Recruiting]

Enoxaparin Versus Unfractionated Heparin in Subjects Who Present to the Emergency Department With Acute Coronary Syndrome (RESCUE) [Completed]

Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25) [Completed]

Safety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention (PCI) Patients, an International Randomized Evaluation (STEEPLE) [Completed]

RE-MODEL Dabigatran Etexilate 150mg or 220mg o.d vs. Enoxaparin 40mg o.d for Prevention of Thrombosis After Knee Surgery [Completed]

Prevention of Venous Thromboembolism in Patients With Acute Primary Intracerebral Hemorrhage [Recruiting]

Efficacy of the Association Mechanical Prophylaxis + Enoxaparin on Venous Thromboembolism Incidence in Intensive Care Unit (ICU) [Recruiting]

Study of an Investigational Drug for the Prevention of Thrombosis-Related Events Following Hip Replacement Surgery [Recruiting]

Thrombelastography Based Dosing of Enoxaparin [Recruiting]

Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture Surgery [Recruiting]

Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement Surgery [Recruiting]

Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement Surgery [Recruiting]

Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery [Recruiting]

Dabigatran Etexilate Compared With Enoxaparin in Prevention of VTE Following Total Hip Arthroplasty [Recruiting]

Heparin or Enoxaparin in Patients With Cancer [Completed]

Evaluation of Pre-Dose and Post-Dose Anti-Factor Xa Levels With Enoxaparin Use During Pregnancy [Completed]

Etude (Study) Phase I Enox - UnFractionated Heparin (UFH) [Completed]

ARIXTRA Local Study For Registration In China. [Completed]

A Study to Evaluate Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee Replacement [Recruiting]

Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted Mobility [Recruiting]

Low Molecular Weight Heparin vs Unfractionated Heparin at Cardiac Surgery [Completed]

EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization [Completed]

Anticoagulant Treatments and Percutaneous Coronary Angioplasty [Recruiting]

Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT) [Completed]

Melagatran/Ximelagatran Versus Enoxaparin for the Prevention of Venous Thromboembolic Events [Terminated]

Michelangelo – Oasis 5 [Completed]

SYNERGY: Open Study of Enoxaparin vs. Unfractionated Heparin in Patients With Acute Coronary Syndromes [Completed]

Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE; a Controlled, Double-Blind, Randomized Study of BAY 59-7939 in the Prevention of VTE in Subjects Undergoing Elective Total Knee Replacement (RECORD 4) [Completed]

Thromboprophylaxis and Bariatric Surgery [Recruiting]

The Use of Low Molecular Weight Heparin in Traumatic Brain Injury

Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement [Recruiting]

Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) Versus Standard CT [Recruiting]

Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery

ABRIDGE: Low Molecular Weight Heparin in Bridging Patients After Mechanical Valve Replacement

Dabigatran Etexilate in Extended VTE Prevention After Hip Replacement Surgery

Patients Preference With Self-Injection: The PRISM Study [Recruiting]

BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery [Completed]

Dabigatran Etexilate vs Enoxaparin in Prevention of VTE Post Total Knee Replacement [Completed]

Comparison of Angiomax Versus Heparin in Acute Coronary Syndromes (ACS) [Completed]

Which Therapy for Acute Heart Attacks? (The WEST Study) [Completed]

An Oral, Direct Factor Xa Inhibitor, BAY 59-7939, for Prophylaxis Against Venous Thromboembolism After Total Knee Replacement: a Dose-Ranging Study [Completed]

Aggrastat to Zocor (AtoZ) - the Use of Two Approved Drugs to Treat Patients Who Have Experienced Chest Pain or a Heart Attack. [Completed]

Comparison of Two Different Dosages of Low-Molecular Weight Heparin in Cancer Patients [Recruiting]

Heparin Induced Thrombocytopenia: Pharmacoeconomics [Active, not recruiting]

Dose-Ranging Study of BAY 59-7939 on the Prevention of VTE in Patients Undergoing Elective Total Hip Replacement- ODIXa-HIP2 Study [Completed]

The Use of Fondaparinux in Preventing Thromboembolism in High Risk Trauma Patients [Recruiting]

Fondaparinux as an Anticoagulant in Haemofiltration in Patients With Acute Kidney Failure. [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014